BIOTECHNOLOGY VALUE FUND L P 13D and 13G filings for PHAXIAM Therapeutics S.A.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-13 6:08 pm Sale |
2022-12-31 | 13G | PHAXIAM Therapeutics S.A. PHXM |
BIOTECHNOLOGY VALUE FUND L P | 51,724 1.600% |
-178,206 (-77.50%) |
Filing |
| 2022-12-23 5:08 pm Sale |
2022-12-21 | 13G | PHAXIAM Therapeutics S.A. PHXM |
BIOTECHNOLOGY VALUE FUND L P | 229,930 7.400% |
-281,988 (-55.08%) |
Filing |
| 2022-02-14 1:49 pm Purchase |
2021-12-31 | 13G | PHAXIAM Therapeutics S.A. PHXM |
BIOTECHNOLOGY VALUE FUND L P | 511,918 16.500% |
103,724 (+25.41%) |
Filing |
| 2021-03-09 9:40 pm Unchanged |
2021-03-08 | 13G | PHAXIAM Therapeutics S.A. PHXM |
BIOTECHNOLOGY VALUE FUND L P | 408,194 19.300% |
0 (Unchanged) |
Filing |
| 2021-01-29 4:36 pm Sale |
2021-01-27 | 13D | PHAXIAM Therapeutics S.A. PHXM |
BIOTECHNOLOGY VALUE FUND L P | 408,194 20.400% |
-38,000 (-8.52%) |
Filing |
| 2021-01-12 5:10 pm Unchanged |
2021-01-08 | 13D | PHAXIAM Therapeutics S.A. PHXM |
BIOTECHNOLOGY VALUE FUND L P | 446,194 22.300% |
0 (Unchanged) |
Filing |
| 2020-10-13 5:18 pm Sale |
2020-10-09 | 13D | PHAXIAM Therapeutics S.A. PHXM |
BIOTECHNOLOGY VALUE FUND L P | 446,194 23.500% |
-8,572 (-1.88%) |
Filing |